Press release
New Study Published: Pneumonia Testing Market Value Expected to Grow $1,738 Mn by 2023
Pneumonia Testing Market
A new report "Pneumonia Testing Market by Method, Technology, Type, End User, and Geography: Global Opportunity Analysis and Industry Forecast, 2017-2023", published by Allied Market Research. The pneumonia testing market accounted for $932 million in 2016, and is estimated to reach $1,738 million by 2023, registering a CAGR of 9.2% from 2017 to 2023.. North America is the highest contributor in the pneumonia testing market in 2016; however, Asia-Pacific is expected to witness the highest growth rate during the forecast period.
Send Enquiry on this report @ https://www.alliedmarketresearch.com/purchase-enquiry/3776
Pneumonia is a type of lung infection caused by bacteria, such as pneumonia (Streptococcus pneumonia), viruses, fungi, and parasites. In pneumonia, the air bladder of the lungs is filled with fluid or pus that causes inflammation in the alveoli. Symptoms of pneumonia include shortness of breath, fever, chest pain, nausea and vomiting. However, these clinical symptoms overlap with many other diseases such as asthma, bronchitis and cold, making it difficult to diagnose pneumonia. Doctors recommend tests such as blood tests, sputum tests, pleural fluid tests and pulse oximetry to check for pneumonia. According to WHO data, pneumonia is one of the causes of child mortality, which accounts for about 1.2 million children under the age of five. The disease is most common in South Asia and Africa.
Recent advancement in pneumonia testing systems such as the development of enhanced nucleic acid detection tests and advancement in POC tests is the major factor that contributes toward the growth of the pneumonia testing market. Moreover, increase in awareness toward early diagnosis and rise in government expenditures on healthcare fuel the market growth. However, limited detection capability & accuracy of some of the pneumonia testing products and regulatory & economic hurdles hamper the market growth. Conversely, surge in adoption of molecular diagnostic testing and high untapped market potential in the developing economies are anticipated to provide lucrative opportunities for the market.
The global pneumonia testing market is segmented on the basis of market, by method, type, technology, end user, and region. In terms of method, the market is classified into immunodiagnostics, molecular diagnostics, and point-of-care (POC) testing. By type, it is bifurcated into analyzers and consumables. Based on technology, it is categorized into enzyme linked immunosorbent assay (ELISA), immunofluorescence, western blot, polymerase chain reaction (PCR), immunohistochemistry (IHC), and others. Depending on end user, it is divided into hospitals, diagnostic laboratories, homecare, and others. Based on region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The POC testing segment was the major contributor to the market in 2016, due to multiple benefits offered by this technique such as technological advancements, ease of use, and rapid results. The consumables segment is estimated to register the highest growth rate during the forecast period, owing to the smaller shelf-life of consumables and their frequent usage for pneumonia tests 2017-2023.
Among the end users, diagnostic laboratories occupied the major share of the pneumonia testing market in 2016, due to large number of tests performed for diagnosis of pneumonia.
Get Access to TOC / Sample Report @ https://www.alliedmarketresearch.com/request-sample/3776
In 2016, North America accounted for maximum contribution to the total revenue generated, owing to rise in prevalence of pneumonia and technological advancements in various pneumonia testing products. However, Asia is projected to grow at the highest CAGR during the forecast period, owing to increase in investments by major companies in R&D activities.
Key Findings of the Pneumonia Testing Market:
• POC testing is projected to grow at the highest rate during the analysis period.
• Diagnostic laboratories segment generated the highest revenue, and is expected to continue its dominance in future.
• North America dominated global pneumonia testing market in 2016, and is projected to continue its dominance in future.
• China is expected to grow highest in the Asia-Pacific region during the forecast period.
• ELISA was the largest contributor among the technologies segments.
The key companies profiled in the report include Thermo Fisher Scientific Inc., Abbott Laboratories, F-Hoffmann la Roche Ltd., Hologic Inc., bioMerieux, Becton, Dickenson and Company, Bio-Rad Laboratories Inc., Meridian Biosciences, Quest Diagnostics, and Quidel.
Other prominent players in the value chain include AdvanDx, Beckman Coulter, Cepheid, Concile, Diamedix, DiaSorin, Fast-track Diagnostics, SeraCare, and Trinity Biotech.
About us
Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release New Study Published: Pneumonia Testing Market Value Expected to Grow $1,738 Mn by 2023 here
News-ID: 1425992 • Views: …
More Releases from Allied Market Research
Speech Analytics Market Expected to Reach to USD 4.9 Billion by 2031, Key Factor …
Allied Market Research published a new report, titled, " The Speech Analytics Market Expected to Reach to USD 4.9 Billion by 2031, Key Factors behind Market's Exponential Growth." The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segment, Porter's Five Forces analysis, and competitive landscape. This study is a helpful source of information for market players, investors, VPs, stakeholders, and new entrants to gain thorough understanding…
Artificial Intelligence in Construction Market Expected to Reach USD 8.6 Billion …
According to the report published by Allied Market Research, The Artificial Intelligence in Construction Market Expected to Reach USD 8.6 Billion by 2031, Growing with at a CAGR of 34.1%. The report provides an extensive analysis of changing market dynamics, major segments, value chain, competitive scenario, and regional landscape. This research offers valuable able guidance to leading players, investors, shareholders, and startups in devising strategies for sustainable growth and gaining…
Seaweed Extracts Market to See Competition Rise | $3.5 Billion by 2032
The seaweed extracts market was valued at $2 billion in 2022, and is estimated to reach $3.5 billion by 2032, growing at a CAGR of 6.1% from 2023 to 2032.
Request Sample PDF Of This Report: https://www.alliedmarketresearch.com/request-sample/A12569
Seaweed extracts refer to concentrated substances derived from different types of seaweed or marine algae. These extracts are obtained through various extraction methods, such as drying, grinding, or chemical processes, resulting in highly potent forms…
Unified Communications as a Service Market Expected to Reach USD 118.8 Billion b …
Allied Market Research published a new report, titled, " The Unified Communications as a Service Market Expected to Reach USD 118.8 Billion by 2031, Key Factors behind Market's Exponential Growth." The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segment, Porter's Five Forces analysis, and competitive landscape. This study is a helpful source of information for market players, investors, VPs, stakeholders, and new entrants to gain…
More Releases for Pneumonia
Market Definitions of Bacterial Pneumonia Treatment
Global Bacterial Pneumonia Treatment Market: Overview
Bacterial pneumonia is an inflammation of the lungs due to bacterial infection. Pneumonia is a common lung infection where the lung’s air sacks become inflamed. Different types of bacteria can cause pneumonia, but Streptococcus pneumonia and Haemophilus influenza are primarily responsible for most of the bacterial pneumonia. Common indications of bacterial pneumonia include cough, chest pain, shortness of breath, fever, and chills.
Read Report Overview -…
Industry Dynamics of Ventilator-associated Pneumonia
Ventilator associated pneumonia (VAP) is an intensive care unit (ICU) for acquired infection. This pulmonary infection generally occurs 48 hours after a patient is incubated and has received mechanical ventilation. Incidence of VAP ranges from 6% to 55% and can reach up to 76% in some situations. VAP is a major cause of illness and death. Patients suffering with VAP have increased spans of ICU hospitalization. Moreover, death rate has…
Global Interstitial Pneumonia Market Growth 2020-2025
Global Interstitial Pneumonia Market Overview:
The global Interstitial Pneumonia market is expected to grow at a significant pace, reports GLOBAL INFO RESEARCH. Its latest research report, titled [Global and United States Interstitial Pneumonia Market 2020 by Company, Type and Application, Forecast to 2025], offers a unique point of view about the global market. Analysts believe that the changing consumption patterns are expected to have a great influence on the overall market. For a…
Global Pneumonia Therapeutics Market 2018 – 2023
Global Pneumonia Therapeutics Market 2018–2023 Poised for xx% Growth
Planet Market Research has recently added a market study named Global Pneumonia Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023 with prime importance on the forecast period from 2018 to 2023. The report is an in-depth analysis of the market for pneumonia therapeutics and covers various driving factors, restraints, opportunities and challenges affecting the market’s growth.
Pneumonia is an…
Pneumonia Drug Development Market Focuses on Top Players (Hospital Acquired Pneu …
Pneumonia Drug Development Market study provides comprehensive data which enhances the understanding, scope and application of this report. Polyamides, polyethylene, nylons, epoxy resins, polysulfones, polyphthalamides, polyesters, and polycarbonates are some key forms of plastics that are employed in electronic components. The insulation properties of plastic account for its in depth use in electrical and electronic components of machines and gadgets.
Report Consultant has introduced a new report titled as Global Pneumonia…
Pneumonia Testing Market Opportunity Analysis, 2018-2026
Pneumonia is a lung infection caused by bacteria, viruses or fungi, primarily affecting the small sir sacs known as alveoli. The most common bacterial type that causes pneumonia is Streptococcus pneumoniae. The symptoms for pneumonia include, fever, chills, cough, shortness of breath and fatigue. To detect whether, a person has pneumonia are blood tests, chest X-ray, pulse oximetry, and Sputum test. Further, if the patients is older than age 65,…
